control group:Carrelizumab + Apatinib mesylate

2 trials

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Conditions

Lung cancer

Early Phase 1

Clinical study of astragalus polysaccharide Injection combined with Carrelizumab and Apatinib in the treatment of lung cancer patients with qi and Yin deficiency and its mechanism of enhancing efficacy and reducing toxicity

RecruitingChiCTR2000040911

First Teaching Hospital of Tianjin University of Traditional Chinese MedicineLung cancer

Start: 2020-12-13Updated: 2021-04-12

Clinical study of astragalus polysaccharide Injection combined with Carrelizumab and Apatinib in the treatment of lung cancer patients with qi and Yin deficiency and its mechanism of enhancing efficacy and reducing toxicity

RecruitingITMCTR2100004691

First Teaching Hospital of Tianjin University of Traditional Chinese MedicineLung cancer

Start: 2020-12-13Updated: 2023-02-20